TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/23 17:00 | 12/22/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | P.d | 17 | 0.7100 | 0 | 24 | 11 | 252 | D | |||||||||||||||
8/23/23 09:28 | 8/21/23 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | P | 12 | 0.5892 | 0 | 20 | 9 | 239 | D | |||||||||||||||
11/15/22 16:07 | 11/14/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | P | 28 | 0.5692 | 0 | 50 | 33 | 200 | M | |||||||||||||||
7/25/22 17:16 | 7/21/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | P | 33 | 1.68 | 0 | 19 | 14 | 160 | D | |||||||||||||||
1/24/22 16:15 | 1/18/22 | ENTX | Entera Bio Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Lieberman Gerald M | L3 | D | P | 8 | 2.80 | 0 | 3 | 2 | 134 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |